最新试用

EudraCT Number: 2005-001084-56

Sponsor Protocol Number: DSC/04/2357/10

Start Date: 2005-05-27

Sponsor Name: ITALFARMACO

Full Title: Phase II Multiple-Dose Clinical Trial of Oral ITF 2357 In Patients with Advanced Multiple Myeloma

Medical condition: multiple myeloma

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10028228		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2005-000395-41

Sponsor Protocol Number: ICORG 05-01

Start Date: 2005-05-27

Sponsor Name: All Ireland co-operative Oncology Research Group

Full Title: Phase II Study to Assess the Safety, Efficacy, and Tolerability of Combination Therapy with Velcade (Bortezomib), Adriamycin, and Dexamethasone (PAD) as Therapy for Patients with relapsed or refra...

Medical condition: Relapsed or refractory Multiple Myeloma

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA) IE (Completed)

Trial results: (No results available)

EudraCT Number: 2005-001202-60

Sponsor Protocol Number: 09/05

Start Date: 2005-05-26

Sponsor Name: Organisation name was not entered

Full Title: Metotreksaatti aksiaalisen spondyloartropatian hoidossa

Medical condition: Aksiaalinen spondyloartropatia (varhainen selkärankareuma)

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: FI (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-003835-30

Sponsor Protocol Number:

Start Date: 2005-05-26

Sponsor Name: Belfast City Hospital

Full Title: An open label, single centre, assessor blind pilot study comparing topical tacrolimus 0.1% and hydrocortisone ointment 1% in the treatment of flexural psoriasis

Medical condition: flexural psoriasis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Female

Trial protocol: GB (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2004-000930-35

Sponsor Protocol Number: MHE100901

Start Date: 2005-05-26

Sponsor Name: GLAXO SMITHKLINE

Full Title: An open-label extension study to study 100185, to evaluate long-term safety, efficacy and optimal dosing frequency of 750mg intravenous mepolizumab in subjects with hypereosinophilic syndrome.

Medical condition: HES

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10005329 - Blood and lymphatic system disorders	10048643	Hypereosinophilic syndrome	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed) BE (Completed)

Trial results: View results

EudraCT Number: 2004-005148-28

Sponsor Protocol Number: 25643

Start Date: 2005-05-26

Sponsor Name: Merck Serono International S.A.

Full Title: A phase III, randomised, double-blind, three-arm, placebo-controlled, multi-center study to evaluate the safety and efficacy of oral Cladribine in subjects with relapsing remitting multiple sclerosis

Medical condition: Relapsing-remitting multiple sclerosis (RRMS)

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10028245		PT

Population Age: Adults

Gender: Male, Female

Trial protocol: FI (Completed) GB (Completed) DK (Completed) EE (Completed) CZ (Completed) BE (Completed) IT (Completed) AT (Completed) SK (Completed) LT (Completed) DE (Completed) LV (Completed)

Trial results: View results

EudraCT Number: 2005-001466-14

Sponsor Protocol Number: MEN002

Start Date: 2005-05-26

Sponsor Name: University of Dundee

Full Title: A Proof of Concept Study to Investigate the use of Simvastatin as a Putative Anti-inflammatory Agent in Asthma

Medical condition: Asthma

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2004-002147-27

Sponsor Protocol Number:

Start Date: 2005-05-26

Sponsor Name: Department of General Psychiatry

Full Title: Influence of treatment of olanzapine and ziprasidone on transcapillary glucose transport in human skeletal muscle

Medical condition: Healthy volunteers

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male

Trial protocol: AT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-004321-95

Sponsor Protocol Number: AMLSG 07-04

Start Date: 2005-05-26

Sponsor Name: University of Ulm

Full Title: RANDOMIZED PHASE II-STUDY ON VALPROIC ACID, ALL-TRANS RETINOIC ACID AND THEIR COMBINATION IN INDUCTION AND CONSOLIDATION THERAPY AS WELL AS PEGFILGRASTIM AFTER CONSOLIDATION THERAPY IN YOUNGER PATI...

Medical condition: newly diagnosed acute myeloid leukemia

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: AT (Ongoing)

Trial results: View results

EudraCT Number: 2004-005088-17

Sponsor Protocol Number: CZOL446EHU03

Start Date: 2005-05-26

Sponsor Name: Novartis Hungária Ltd.

Full Title: A multicenter, Open-label Study to Determine the Effect of I.V. Zometa on Pain and Quality of Life in Patients with Bone Metastases with or without Skeletal Related Events (SREs) Resulting from Bre...

Medical condition: Patients will have bone metastases with or without skeletal related events (SREs) from breast cancer and prostate cancer.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed)

Trial results: View results

最新试用

赞助者和合作者

医疗条件

药物干预